Drug Discovery for Neurodegeneration Conference 2015

Designed as a comprehensive course on the drug discovery process, from target validation through to clinical development, the annual Drug Discovery for Neurodegeneration conference provides participants with the fundamental knowledge and resources to translate their research into new drugs to treat and prevent Alzheimer's disease and related neurodegenerative diseases.

Attendees from academia and industry will also learn from specific case studies examples and will have an opportunity to engage in interactive discussions on securing partnerships.

The program will include a focus on Alzheimer’s disease, Parkinson’s disease and Multiple Sclerosis.

Speakers:
Tilmann Brotz, PhD—Konzept Drug Development Consulting
Steven Chang, PhD—New York Stem Cell Foundation
Anthony Coyle, PhD—Pfizer, Centers for Therapeutic Innovation (CTI)
Thomas Chung, PhD—Sanford Burnham
Roberta Diaz Brinton, PhD—University of California, Irvine
Howard Fillit, MD—Alzheimer’s Drug Discovery Foundation
Julie Frearson, PhD—BioFocus
Marcie Glicksman, PhD—Harvard NeuroDiscovery Center
Barry Greenberg, PhD—University Health Network
Leroy Hood, MD, PhD—Institute for Systems Biology
William Janzen—University of North Carolina, Chapel Hill
Frank Longo, MD, PhD—Stanford University and PharmatrophiX
and many more...